Editorial

STATUS OF PUVA THERAPY

Authors: Kim B. Yancey, MD, J. Graham Smith, Jr., MD

Abstract

Treatment of psoriasis with oral methoxsalen (psoralen) followed by long-wave ultraviolet light (PUVA) was first introduced in 1974.1 A consensus report of 29 clinical investigators participating in two cooperative clinical trials with psoriatics in the most thorough review of PUVA published to date discusses guidelines for patient selection, application of therapy, contraindications to treatment, and follow-up recommendations.2

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References